Key Points
- Andreas Wagner sold 21,118 shares of Alignment Healthcare on March 4 at an average price of $18.62 for about $393,217, reducing his position by 12.44% to 148,687 shares valued at roughly $2.77 million.
- Alignment Healthcare beat quarterly EPS expectations (reported ($0.05) vs. consensus ($0.15)) and posted $1.01 billion in revenue, up 44.4% year-over-year.
- Wall Street sentiment is broadly positive with an average rating of "Moderate Buy" and an average target of $24.56 (several $25–$28 targets), while institutional investors own about 86.2% of the stock after large stake increases by firms like Wellington and Invesco.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Andreas Wagner sold 21,118 shares of the business's stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $18.62, for a total value of $393,217.16. Following the completion of the transaction, the insider owned 148,687 shares in the company, valued at approximately $2,768,551.94. This trade represents a 12.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Alignment Healthcare Stock Down 1.1%
NASDAQ ALHC traded down $0.20 during mid-day trading on Thursday, reaching $18.68. 263,068 shares of the company's stock traded hands, compared to its average volume of 2,891,089. The company has a current ratio of 1.71, a quick ratio of 1.61 and a debt-to-equity ratio of 1.80. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $23.87. The company has a fifty day simple moving average of $20.96 and a 200-day simple moving average of $18.63. The company has a market cap of $3.82 billion, a price-to-earnings ratio of -1,866.13, a P/E/G ratio of 2.70 and a beta of 1.18.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.10. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The company had revenue of $1.01 billion during the quarter, compared to analysts' expectations of $1 billion. During the same period in the prior year, the business posted ($0.16) EPS. The business's revenue was up 44.4% on a year-over-year basis. As a group, equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on ALHC. Robert W. Baird set a $28.00 target price on shares of Alignment Healthcare in a research report on Friday, January 30th. Wall Street Zen upgraded Alignment Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, February 7th. UBS Group upped their price objective on Alignment Healthcare from $18.00 to $21.00 and gave the company a "neutral" rating in a research note on Wednesday, January 14th. KeyCorp reaffirmed an "overweight" rating and set a $28.00 target price on shares of Alignment Healthcare in a report on Thursday, January 22nd. Finally, TD Cowen boosted their price target on Alignment Healthcare from $18.50 to $25.00 and gave the company a "buy" rating in a report on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Alignment Healthcare currently has an average rating of "Moderate Buy" and an average target price of $24.56.
Check Out Our Latest Analysis on Alignment Healthcare
Hedge Funds Weigh In On Alignment Healthcare
A number of hedge funds and other institutional investors have recently bought and sold shares of ALHC. Wellington Management Group LLP grew its holdings in shares of Alignment Healthcare by 167.3% during the third quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company's stock valued at $193,516,000 after purchasing an additional 6,940,277 shares during the last quarter. Invesco Ltd. increased its position in Alignment Healthcare by 122.3% in the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company's stock worth $58,387,000 after buying an additional 2,294,739 shares during the period. Capital World Investors bought a new stake in Alignment Healthcare in the fourth quarter valued at $44,203,000. Loomis Sayles & Co. L P acquired a new position in shares of Alignment Healthcare during the fourth quarter valued at $44,162,000. Finally, Danica Pension Livsforsikringsaktieselskab acquired a new position in shares of Alignment Healthcare during the fourth quarter valued at $39,500,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
